ATP Dependent Efflux Transporters ABCB1 and ABCG2 Are Unlikely to Impact the Efficacy, or Mediate Resistance to the Tyrosine Kinase Inhibitor, Ponatinib

被引：0
|
作者：
White, Deborah L. [1 ]
Lu, Liu [1 ]
Clackson, Timothy P. [3 ]
Saunders, Verity A. [2 ]
Hughes, Timothy P. [4 ]
机构：
[1] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia
[2] Ctr Canc Biol SA Pathol RAH Site, Dept Haematol, Adelaide, SA, Australia
[3] ARIAD Pharmaceut, Adelaide, SA, Australia
[4] Univ Adelaide, Ctr Personalised Canc Med, Adelaide, SA, Australia
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1180 / 1180
页数：1
相关论文
共 50 条
  • [21] Vodobatinib overcomes cancer multidrug resistance by attenuating the drug efflux function of ABCB1 and ABCG2
    Li, Yen-Ching
    Lin, Bing-Huan
    Murakami, Megumi
    Wu, Yu-Shan
    Hung, Tai-Ho
    Chen, Chin-Chuan
    V. Ambudkar, Suresh
    Wu, Chung-Pu
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 988
  • [22] Human ABCB1 (P-glycoprotein) and ABCG2 mediate resistance to BI 2536, a potent and selective inhibitor of Polo-like kinase 1
    Wu, Chung-Pu
    Hsiao, Sung-Han
    Sim, Hong-May
    Luo, Shi-Yu
    Tuo, Wei-Cherng
    Cheng, Hsing-Wen
    Li, Yan-Qing
    Huang, Yang-Hui
    Ambudkar, Suresh V.
    BIOCHEMICAL PHARMACOLOGY, 2013, 86 (07) : 904 - 913
  • [23] Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells
    Wu, Chung-Pu
    Li, Yen-Ching
    Murakami, Megumi
    Hsiao, Sung-Han
    Lee, Yun-Chieh
    Huang, Yang-Hui
    Chang, Yu-Tzu
    Hung, Tai-Ho
    Wu, Yu-Shan
    Ambudkar, Suresh V.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (18)
  • [24] Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro
    Cihalova, Daniela
    Ceckova, Martina
    Kucera, Radim
    Klimes, Jiri
    Staud, Frantisek
    BIOCHEMICAL PHARMACOLOGY, 2015, 98 (03) : 465 - 472
  • [25] Impact of ABCB1 and ABCG2 Transporter in Outcome of Gallbladder Cancer
    Nimisha
    Saluja, Sundeep S.
    Sharma, Abhay K.
    Nekarakanti, Phani K.
    Apurva, Arun
    Kumar, Arun
    Ahmad, Ejaj
    Husain, Syed A.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2024, 14 (05)
  • [26] ABCB1, ABCC1 AND ABCG2 Transporters Expression in 180 Primary Retinoblastoma
    Cabrera-Munoz, Lourdes
    Ponce, M.
    Sadowinski-Pine, Stanislaw
    Manuela, Orjuela
    Gomez, Alejandro
    Loyola, Ofelia
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1602 - 1602
  • [27] ABCB1, ABCC1 AND ABCG2 Transporters Expression in 180 Primary Retinoblastoma
    Cabrera-Munoz, Lourdes
    Ponce, M.
    Sadowinski-Pine, Stanislaw
    Manuela, Orjuela
    Gomez, Alejandro
    Loyola, Ofelia
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1602 - 1602
  • [28] Epertinib counteracts multidrug resistance in cancer cells by antagonizing the drug efflux function of ABCB1 and ABCG2
    Lin, Bing-Huan
    Li, Yen-Ching
    Murakami, Megumi
    Wu, Yu-Shan
    Huang, Yang-Hui
    Hung, Tai-Ho
    Ambudkar, Suresh. V.
    Wu, Chung-Pu
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 180
  • [29] Synthesis and SAR Study of Anticancer Protoflavone Derivatives: Investigation of Cytotoxicity and Interaction with ABCB1 and ABCG2 Multidrug Efflux Transporters
    Danko, Balazs
    Toth, Szilard
    Martins, Ana
    Vagvolgyi, Mate
    Kusz, Norbert
    Molnar, Joseph
    Chang, Fang-Rong
    Wu, Yang-Chang
    Szakacs, Gergely
    Hunyadi, Attila
    CHEMMEDCHEM, 2017, 12 (11) : 850 - 859
  • [30] DISEASE ACTIVITY PREDICTS ABCB1 AND ABCG2 DRUG-EFFLUX TRANSPORTERS FUNCTION IN RHEUMATOID ARTHRITIS (RA) PATIENTS
    Ramos, V. Pascual
    Atisha-Fregoso, Y.
    Fragoso-Loyo, H.
    Ocampo, J. Jakez
    Lima, G.
    Banos, M.
    Contreras-Yanez, I.
    Llorente, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 427 - 428
12345